A recent research report released by Fact.MR, a provider of competitive intelligence and market research, projects that the global Arbovirus Testing Market will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2034, with a valuation of US$ 2.49 billion by the end of the forecast period.

It is anticipated that increased arbovirus infections—such as dengue fever and Zika virus infection—caused by travel and climate change will increase demand for testing products. It is anticipated that the number of arbovirus infections would rise, increasing the need for prompt and precise diagnostic tests in order to provide patients with the care they need.

Get Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=9182

A significant increase in arbovirus cases is anticipated to lead to a rising focus on prevention, surveillance, and control measures, which are predicted to accelerate the need for efficient and reliable arbovirus testing solutions. These factors are projected to result in noteworthy advancements in diagnostic technologies along with the development of novel testing methods.

Constant advancements in technologies, including serological assays, point-of-care testing, and molecular diagnostics for accurate and rapid detection of arboviruses are predicted to lead to improved public health interventions.

Key Takeaways from the Market Study

• Worldwide demand for arbovirus testing is estimated at a value of US$ 1.43 billion in 2024.
• The global arbovirus testing market is forecasted to reach US$ 2.49 billion by the end of 2034.
• Global demand for arbovirus testing is predicted to increase at 5.7% CAGR from 2024 to 2034.
• North America is projected to account for an 18.1% share of global market revenue by 2034.
• Sales of arbovirus testing tools in the United States are predicted to rise at 4.1% CAGR and reach US$ 286 million by the end of 2034.
• China is forecasted to hold a 46.7% share of the East Asia market by 2034.
• Global demand for ELISA-based tests is predicted to increase at 5.6% CAGR and reach a valuation of US$ 1.47 billion by 2034-end.

“Increasing cases of arthropod-borne diseases, government initiatives aimed to control and prevent arbovirus outbreaks, and advancements in diagnostic technologies are estimated to stimulate demand for arbovirus testing,” says a Fact.MR analyst.

Leading Market Players

Key providers of arbovirus testing solutions are

• Agilent Technologies Inc.,
• NovaTec Immundiagnostica GmbH,
• Thermo Fisher Scientific,
• Euroeimmun AG,
• Abbot Laboratories,
• Bio-Rad,
• DiaSorin SpA,
• Fluke Biomedical,
• Distek,
• Copley Scientific,
• Becton,
• Distek,
• Dickinson and Company,
• Hoffmann La Roche Ltd.,
• Merck kGaA F,
• QIAGEN N.V.,
• Siemens Healthineers AG.

Widespread Availability of Point-of-Care Molecular Diagnostics in Clinical Facilities in the United States

The United States is predicted to hold a 63.4% share of the North American market by 2034. Increased demand for arbovirus testing is attributed to the availability of point-of-care molecular diagnostics across clinical facilities in the United States.

The presence of a well-established healthcare infrastructure, extensive use of sophisticated diagnostic tests, and increased R&D expenditures are predicted to positively impact the arbovirus testing market. Moreover, the development of integrated response strategies to reduce the cases of arbovirus is predicted to increase the adoption of respective tests.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=9182

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the arbovirus testing market, presenting historical demand data for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on test type (ELISA-based tests, RT-PCR tests) and end-user (hospitals, public health laboratories, diagnostic centers) across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).

Competitive Landscape:

Prominent suppliers of arbovirus testing tools are adopting several strategies to achieve set purposes, including management of supply chain systems, ensuring quality control of products, and innovations. Companies are implementing several growth strategies, including product launches and collaborations, to gain a competitive edge.

For instance :

• Mylab, in July 2022, launched the PathoDetect Extended Monsoon Fever Panel. This newly developed RT-PCR test kit works more effectively for monsoon disorders, including dengue, malaria, and Zika. This newly developed kit offers accurate results in two hours along with a mass testing feature.

Browse Full Report @ https://www.factmr.com/report/arbovirus-testing-market

Segmentation of Arbovirus Testing Market Research

• By Test Type :
  • ELISA-based Tests
  • RT-PCR Tests
• By End User :
  • Hospitals
  • Public Health Laboratories
  • Diagnostic Centers
• By Region :
  • North America
  • Europe
  • East Asia
  • Latin America
  • Middle East & Africa
  • South Asia & Oceania

Category-wise Insights:

According to the study published by Fact.MR, a market research and competitive intelligence provider, public health laboratories are predicted to adopt arbovirus testing services extensively to promote knowledge sharing, improve testing accuracy, and standardize testing protocols.

Related Publish by Fact.MR Industry:

Home Infusion Therapy Market

https://www.factmr.com/report/home-infusion-therapy-market

Hemato Oncology Testing Market

https://www.factmr.com/report/hemato-oncology-testing-market

Pulse Oximeters Market

https://www.factmr.com/report/4449/pulse-oximeters-market

Surgical Headlights Market

https://www.factmr.com/report/surgical-headlights-market